Synthetic biology firm Ginkgo Bioworks acquires DNA synthesis provider Gen9

February 02, 2017 | Analyst Insight

Recently, Ginkgo Bioworks announced the acquisition of DNA synthesis provider Gen9 for an undisclosed amount of cash and stock. Ginkgo will integrate into its existing Bioworks facilities Gen9's BioFab platform, which includes...